Marco Siringo

8PUBLICATIONS
80CO-AUTHORS
Predictive and prognostic markersMolecular targetsOncology and carcinogenesis not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 19, 2025
The ACCEPTance of automation: refining circulating tumor cells enumeration for improved metastatic colorectal cancer prognosis.

Michela De Meo, Marco Siringo, Alessandro Vici

|Apr 14, 2025
Evolution of Neo-RAS-WT in Circulating Tumor DNA from First-Line to Subsequent Therapies in Metastatic Colorectal Cancer.

Marco Siringo, Michela De Meo, Irene Bottillo

|Mar 28, 2025
Immunological Network Signature of Naïve Non-Oncogene-Addicted Non-Small Cell Lung Cancer Patients Treated with Anti-PD1 Therapy: A Pilot Study.

Pasquale Sibilio, Ilaria Grazia Zizzari, Alain Gelibter

|Oct 26, 2024
Blood Extracellular Vesicles Beyond Circulating Tumour Cells: A Valuable Risk Stratification Biomarker in High-Risk Non-Muscle-Invasive Bladder Cancer Patients.

Valentina Magri, Luca Marino, Francesco Del Giudice

|Apr 13, 2024
Circulating Cancer-Associated Macrophage-like Cells as a Blood-Based Biomarker of Response to Immune Checkpoint Inhibitors.

Valentina Magri, Gianluigi De Renzi, Luca Marino

|Dec 09, 2023
Future Perspectives in the Second Line Therapeutic Setting for Non-Oncogene Addicted Non-Small-Cell Lung Cancer.

Marco Siringo, Javier Baena, Helena Bote de Cabo

Pageof 2

Frequent Collaborators

4 joint publications

Michela De Meo

3 joint publications

Chiara Nicolazzo

3 joint publications

Paola Gazzaniga

2 joint publications

Luca Marino